GIST Scientists Boost Voice Pathology Detection Using Adversarial Learning

GIST (Gwangju Institute of Science and Technology)

Voice pathology refers to a problem arising from abnormal conditions, such as dysphonia, paralysis, cysts, and even cancer, that cause abnormal vibrations in the vocal cords (or vocal folds). In this context, voice pathology detection (VPD) has received much attention as a non-invasive way to automatically detect voice problems. It consists of two processing modules: a feature extraction module to characterize normal voices and a voice detection module to detect abnormal ones. Machine learning methods like support vector machines (SVM) and convolutional neural networks (CNN) have been successfully utilized as pathological voice detection modules to achieve good VPD performance. Also, a self-supervised, pretrained model can learn generic and rich speech feature representation, instead of explicit speech features, which further improves its VPD abilities. However, fine-tuning these models for VPD leads to an overfitting problem, due to a domain shift from conversation speech to the VPD task. As a result, the pretrained model becomes too focused on the training data and does not perform well on new data, preventing generalization.

To mitigate this problem, a team of researchers from Gwangju Institute of Science and Technology (GIST) in South Korea, led by Prof. Hong Kook Kim, has proposed a groundbreaking contrastive learning method involving Wave2Vec 2.0—a self-supervised pretrained model for speech signals—with a novel approach called adversarial task adaptive pretraining (A-TAPT). Herein, they incorporated adversarial regularization during the continual learning process.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.